Document is current

Any future updates will be listed below

Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients

Crossref DOI link: https://doi.org/10.1007/s12282-025-01672-z

Published Online: 2025-01-29

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark